IC Value-Added Distribution Business Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 8 | Pages : 97 |
The global Artificial Intelligence-driven Drug Development market was valued at US$ 1405.9 million in 2022 and is projected to reach US$ 8513.8 million by 2029, at a CAGR of 29.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hardware Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence-driven Drug Development include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence-driven Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence-driven Drug Development. This report contains market size and forecasts of Artificial Intelligence-driven Drug Development in global, including the following market information:
Global Artificial Intelligence-driven Drug Development Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Intelligence-driven Drug Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence-driven Drug Development Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence-driven Drug Development Market Segment Percentages, by Type, 2022 (%)
Hardware
Software
Service
Global Artificial Intelligence-driven Drug Development Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Artificial Intelligence-driven Drug Development Market Segment Percentages, by Application, 2022 (%)
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
Global Artificial Intelligence-driven Drug Development Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Artificial Intelligence-driven Drug Development Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence-driven Drug Development revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Artificial Intelligence-driven Drug Development revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artificial Intelligence-driven Drug Development, market overview.
Chapter 2: Global Artificial Intelligence-driven Drug Development market size in revenue.
Chapter 3: Detailed analysis of Artificial Intelligence-driven Drug Development company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Intelligence-driven Drug Development in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence-driven Drug Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence-driven Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence-driven Drug Development Overall Market Size
2.1 Global Artificial Intelligence-driven Drug Development Market Size: 2022 VS 2029
2.2 Global Artificial Intelligence-driven Drug Development Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence-driven Drug Development Players in Global Market
3.2 Top Global Artificial Intelligence-driven Drug Development Companies Ranked by Revenue
3.3 Global Artificial Intelligence-driven Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence-driven Drug Development Companies in Global Market, by Revenue in 2022
3.5 Global Companies Artificial Intelligence-driven Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence-driven Drug Development Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence-driven Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence-driven Drug Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Artificial Intelligence-driven Drug Development Market Size Markets, 2022 & 2029
4.1.2 Hardware
4.1.3 Software
4.1.4 Service
4.2 By Type - Global Artificial Intelligence-driven Drug Development Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence-driven Drug Development Revenue, 2018-2023
4.2.2 By Type - Global Artificial Intelligence-driven Drug Development Revenue, 2024-2029
4.2.3 By Type - Global Artificial Intelligence-driven Drug Development Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence-driven Drug Development Market Size, 2022 & 2029
5.1.2 Early Drug Discovery
5.1.3 Preclinical Phase
5.1.4 Clinical Phase
5.1.5 Regulatory Approval
5.2 By Application - Global Artificial Intelligence-driven Drug Development Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence-driven Drug Development Revenue, 2018-2023
5.2.2 By Application - Global Artificial Intelligence-driven Drug Development Revenue, 2024-2029
5.2.3 By Application - Global Artificial Intelligence-driven Drug Development Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Artificial Intelligence-driven Drug Development Market Size, 2022 & 2029
6.2 By Region - Global Artificial Intelligence-driven Drug Development Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence-driven Drug Development Revenue, 2018-2023
6.2.2 By Region - Global Artificial Intelligence-driven Drug Development Revenue, 2024-2029
6.2.3 By Region - Global Artificial Intelligence-driven Drug Development Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Artificial Intelligence-driven Drug Development Revenue, 2018-2029
6.3.2 US Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.3.3 Canada Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.3.4 Mexico Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence-driven Drug Development Revenue, 2018-2029
6.4.2 Germany Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.3 France Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.4 U.K. Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.5 Italy Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.6 Russia Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.7 Nordic Countries Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.4.8 Benelux Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence-driven Drug Development Revenue, 2018-2029
6.5.2 China Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.5.3 Japan Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.5.4 South Korea Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.5.5 Southeast Asia Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.5.6 India Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Artificial Intelligence-driven Drug Development Revenue, 2018-2029
6.6.2 Brazil Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.6.3 Argentina Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence-driven Drug Development Revenue, 2018-2029
6.7.2 Turkey Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.7.3 Israel Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.7.4 Saudi Arabia Artificial Intelligence-driven Drug Development Market Size, 2018-2029
6.7.5 UAE Artificial Intelligence-driven Drug Development Market Size, 2018-2029
7 Artificial Intelligence-driven Drug Development Companies Profiles
7.1 IBM
7.1.1 IBM Company Summary
7.1.2 IBM Business Overview
7.1.3 IBM Artificial Intelligence-driven Drug Development Major Product Offerings
7.1.4 IBM Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.1.5 IBM Key News & Latest Developments
7.2 Exscientia
7.2.1 Exscientia Company Summary
7.2.2 Exscientia Business Overview
7.2.3 Exscientia Artificial Intelligence-driven Drug Development Major Product Offerings
7.2.4 Exscientia Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.2.5 Exscientia Key News & Latest Developments
7.3 Google(Alphabet)
7.3.1 Google(Alphabet) Company Summary
7.3.2 Google(Alphabet) Business Overview
7.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Major Product Offerings
7.3.4 Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.3.5 Google(Alphabet) Key News & Latest Developments
7.4 Microsoft
7.4.1 Microsoft Company Summary
7.4.2 Microsoft Business Overview
7.4.3 Microsoft Artificial Intelligence-driven Drug Development Major Product Offerings
7.4.4 Microsoft Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.4.5 Microsoft Key News & Latest Developments
7.5 Atomwise
7.5.1 Atomwise Company Summary
7.5.2 Atomwise Business Overview
7.5.3 Atomwise Artificial Intelligence-driven Drug Development Major Product Offerings
7.5.4 Atomwise Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.5.5 Atomwise Key News & Latest Developments
7.6 Schrodinger
7.6.1 Schrodinger Company Summary
7.6.2 Schrodinger Business Overview
7.6.3 Schrodinger Artificial Intelligence-driven Drug Development Major Product Offerings
7.6.4 Schrodinger Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.6.5 Schrodinger Key News & Latest Developments
7.7 Aitia
7.7.1 Aitia Company Summary
7.7.2 Aitia Business Overview
7.7.3 Aitia Artificial Intelligence-driven Drug Development Major Product Offerings
7.7.4 Aitia Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.7.5 Aitia Key News & Latest Developments
7.8 Insilico Medicine
7.8.1 Insilico Medicine Company Summary
7.8.2 Insilico Medicine Business Overview
7.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Major Product Offerings
7.8.4 Insilico Medicine Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.8.5 Insilico Medicine Key News & Latest Developments
7.9 NVIDIA
7.9.1 NVIDIA Company Summary
7.9.2 NVIDIA Business Overview
7.9.3 NVIDIA Artificial Intelligence-driven Drug Development Major Product Offerings
7.9.4 NVIDIA Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.9.5 NVIDIA Key News & Latest Developments
7.10 XtalPi
7.10.1 XtalPi Company Summary
7.10.2 XtalPi Business Overview
7.10.3 XtalPi Artificial Intelligence-driven Drug Development Major Product Offerings
7.10.4 XtalPi Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.10.5 XtalPi Key News & Latest Developments
7.11 BPGbio
7.11.1 BPGbio Company Summary
7.11.2 BPGbio Business Overview
7.11.3 BPGbio Artificial Intelligence-driven Drug Development Major Product Offerings
7.11.4 BPGbio Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.11.5 BPGbio Key News & Latest Developments
7.12 Owkin
7.12.1 Owkin Company Summary
7.12.2 Owkin Business Overview
7.12.3 Owkin Artificial Intelligence-driven Drug Development Major Product Offerings
7.12.4 Owkin Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.12.5 Owkin Key News & Latest Developments
7.13 CytoReason
7.13.1 CytoReason Company Summary
7.13.2 CytoReason Business Overview
7.13.3 CytoReason Artificial Intelligence-driven Drug Development Major Product Offerings
7.13.4 CytoReason Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.13.5 CytoReason Key News & Latest Developments
7.14 Deep Genomics
7.14.1 Deep Genomics Company Summary
7.14.2 Deep Genomics Business Overview
7.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Major Product Offerings
7.14.4 Deep Genomics Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.14.5 Deep Genomics Key News & Latest Developments
7.15 Cloud Pharmaceuticals
7.15.1 Cloud Pharmaceuticals Company Summary
7.15.2 Cloud Pharmaceuticals Business Overview
7.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Major Product Offerings
7.15.4 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.15.5 Cloud Pharmaceuticals Key News & Latest Developments
7.16 BenevolentAI
7.16.1 BenevolentAI Company Summary
7.16.2 BenevolentAI Business Overview
7.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Major Product Offerings
7.16.4 BenevolentAI Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.16.5 BenevolentAI Key News & Latest Developments
7.17 Cyclica
7.17.1 Cyclica Company Summary
7.17.2 Cyclica Business Overview
7.17.3 Cyclica Artificial Intelligence-driven Drug Development Major Product Offerings
7.17.4 Cyclica Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.17.5 Cyclica Key News & Latest Developments
7.18 Verge Genomics
7.18.1 Verge Genomics Company Summary
7.18.2 Verge Genomics Business Overview
7.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Major Product Offerings
7.18.4 Verge Genomics Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.18.5 Verge Genomics Key News & Latest Developments
7.19 Valo Health
7.19.1 Valo Health Company Summary
7.19.2 Valo Health Business Overview
7.19.3 Valo Health Artificial Intelligence-driven Drug Development Major Product Offerings
7.19.4 Valo Health Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.19.5 Valo Health Key News & Latest Developments
7.20 Envisagenics
7.20.1 Envisagenics Company Summary
7.20.2 Envisagenics Business Overview
7.20.3 Envisagenics Artificial Intelligence-driven Drug Development Major Product Offerings
7.20.4 Envisagenics Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.20.5 Envisagenics Key News & Latest Developments
7.21 Euretos
7.21.1 Euretos Company Summary
7.21.2 Euretos Business Overview
7.21.3 Euretos Artificial Intelligence-driven Drug Development Major Product Offerings
7.21.4 Euretos Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.21.5 Euretos Key News & Latest Developments
7.22 BioAge Labs
7.22.1 BioAge Labs Company Summary
7.22.2 BioAge Labs Business Overview
7.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Major Product Offerings
7.22.4 BioAge Labs Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.22.5 BioAge Labs Key News & Latest Developments
7.23 Iktos
7.23.1 Iktos Company Summary
7.23.2 Iktos Business Overview
7.23.3 Iktos Artificial Intelligence-driven Drug Development Major Product Offerings
7.23.4 Iktos Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.23.5 Iktos Key News & Latest Developments
7.24 BioSymetrics
7.24.1 BioSymetrics Company Summary
7.24.2 BioSymetrics Business Overview
7.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Major Product Offerings
7.24.4 BioSymetrics Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.24.5 BioSymetrics Key News & Latest Developments
7.25 Evaxion Biotech
7.25.1 Evaxion Biotech Company Summary
7.25.2 Evaxion Biotech Business Overview
7.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Major Product Offerings
7.25.4 Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.25.5 Evaxion Biotech Key News & Latest Developments
7.26 Aria Pharmaceuticals
7.26.1 Aria Pharmaceuticals Company Summary
7.26.2 Aria Pharmaceuticals Business Overview
7.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Major Product Offerings
7.26.4 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue in Global Market (2018-2023)
7.26.5 Aria Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Commercial Blanket Cleaning Service Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 8 | Pages : 144 |
Project Management Software in Biotechnology Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 8 | Pages : 131 |
Voice Switch System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 8 | Pages : 113 |
High Pressure Cleaning Repair Service Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 8 | Pages : 92 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
